A dual-vector phospholipid nanosystem of doxorubicin: accumulation and cytotoxic effect in breast cancer cells in vitro
Biomeditsinskaya Khimiya · 2023-12 · 69 (6) · 409-419
DOI: 10.18097/pbmc20236906409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2023. Verfasst von Yu A Tereshkina und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, Moscow, Russia. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Various chemotherapeutic agents are used to treat breast cancer (BC); one of them is the anthracycline antibiotic doxorubicin (Dox), which, in addition to its cytostatic effect, has serious side effects. In order to reduce its negative impact on healthy organs and tissues and to increase its accumulation in tumors, Dox was incorporated into phospholipid nanoparticles. The additional use of vector molecules for targeted delivery to specific targets can increase the effectiveness of Dox due to higher accumulation of the active substance in the tumor tissue. The integrin αvβ3, which plays an important role in cancer angiogenesis, and the folic acid receptor, which is responsible for cell differentiation and proliferation, have been considered in this study as targets for such vector molecules. Thus, a phospholipid composition of Dox containing two vector ligands, cRGD peptide and folic acid (NPh-Dox-cRGD-Fol(3,4)), was prepared. Study of the physical properties of the developed composition NPh-Dox-cRGD-Fol(3,4) showed that the average particle size was 39.62±4.61 nm, the ζ-potential value was 4.17±0.83 mV. Almost all Dox molecules were incorporated into phospholipid nanoparticles (99.85±0.21%). The simultaneous use of two vectors in the composition led to an increase in the Dox accumulation in MDA-MB-231 BC cells by almost 20% as compared to compositions containing each vector separately (folic acid or the cRGD peptide). Moreover, the degree of Dox internalization was 22% and 24% higher than in the case of separate use of folic acid and cRGD peptide, respectively. The cytotoxic effect on MDA-MB-231 cells was higher during incubations with the compositions containing folic acid as a single vector (NPh-Dox-Fol(3,4)) and together with the RGD peptide (NPh-Dox-cRGD-Fol(3,4)). Experiments on the Wi-38 diploid fibroblast cell line have shown a significantly lower degree of cytotoxic effect of the phospholipid composition, regardless of the presence of the vector molecules in it, as compared to free Dox. The results obtained indicate the potential of using two vectors in one phospholipid composition for targeted delivery of Dox.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Chemistry, Moscow, Russia.
Zitieren
APA
Tereshkina, Y. A., Bedretdinov, F. N., & Kostryukova, L. V. (2023). A dual-vector phospholipid nanosystem of doxorubicin: accumulation and cytotoxic effect in breast cancer cells in vitro. Biomeditsinskaya Khimiya, 69(6), 409-419. https://doi.org/10.18097/pbmc20236906409
Vancouver
Tereshkina YA, Bedretdinov FN, Kostryukova LV. A dual-vector phospholipid nanosystem of doxorubicin: accumulation and cytotoxic effect in breast cancer cells in vitro. Biomeditsinskaya Khimiya. 2023;69(6):409-419. doi:10.18097/pbmc20236906409
BibTeX
@article{Tereshkina2023,
author = {Tereshkina, Yu A and Bedretdinov, F N and Kostryukova, L V},
title = {A dual-vector phospholipid nanosystem of doxorubicin: accumulation and cytotoxic effect in breast cancer cells in vitro},
journal = {Biomeditsinskaya Khimiya},
year = {2023},
volume = {69},
number = {6},
pages = {409--419},
doi = {10.18097/pbmc20236906409}
}
EUVIMED